UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

Journal of clinical oncology, 2009-12, Vol.27 (34), p.5763-5771

2009

Volltextzugriff (PDF)

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Journal of clinical oncology, 2004-01, Vol.22 (1), p.77-85

2004

Volltextzugriff (PDF)

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4953-4960

2010

Volltextzugriff (PDF)

MicroRNA profile analysis of human prostate cancers

Cancer gene therapy, 2009-03, Vol.16 (3), p.206-216

2009

Volltextzugriff (PDF)

Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development

Cancer gene therapy, 2009-11, Vol.16 (11), p.807-809

2009

Volltextzugriff (PDF)

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

British journal of cancer, 2013-01, Vol.108 (1), p.21-24

2013

Volltextzugriff (PDF)

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

BMC cancer, 2009-07, Vol.9 (1), p.263-263, Article 263

2009

Volltextzugriff (PDF)

A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours

British journal of cancer, 2013-09, Vol.109 (5), p.1085-1092

2013

Volltextzugriff (PDF)

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

Cancer gene therapy, 2009-08, Vol.16 (8), p.620-624

2009

Volltextzugriff (PDF)

Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2009-08, Vol.21 (6), p.464-472

2009

Volltextzugriff (PDF)

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial

Cancer, 2001-08, Vol.92 (4), p.875-885

2001

Volltextzugriff (PDF)

A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients

Cancer gene therapy, 2007-11, Vol.14 (11), p.885-893

2007

Volltextzugriff (PDF)

Transcription factors: their potential as targets for an individualized therapeutic approach to cancer

Cancer gene therapy, 2009-02, Vol.16 (2), p.103-112

2009

Volltextzugriff (PDF)

Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform

Cancer gene therapy, 2014-02, Vol.21 (2), p.48-53

2014

Volltextzugriff (PDF)

Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): Early termination due to increased toxicities

Clinical cancer research, 2004-10, Vol.10 (19), p.6522-6527

2004

Volltextzugriff (PDF)

siRNA vs. shRNA: Similarities and differences

Advanced drug delivery reviews, 2009-07, Vol.61 (9), p.746-759

2009

Volltextzugriff (PDF)

Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results

Gynecologic oncology, 2015-04, Vol.137, p.2-3

2015

Volltextzugriff (PDF)

Phase I Clinical Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features

Clinical cancer research, 2011-02, Vol.17 (4), p.888-895

2011

Volltextzugriff (PDF)

Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer

Journal of clinical oncology, 2010-06, Vol.28 (18), p.2958-2965

2010

Volltextzugriff (PDF)

Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine

Gene therapy, 2013-09, Vol.20 (9), p.875-879

2013

Volltextzugriff (PDF)

Immune response and survival of refractory cancer patients who received TGF- beta 2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine

Gene therapy, 2013-09, Vol.20 (9), p.875-879

2013

Volltextzugriff (PDF)

Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference

Cancer gene therapy, 2010-11, Vol.17 (11), p.780-791

2010

Volltextzugriff (PDF)

Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study

Journal for immunotherapy of cancer, 2016-03, Vol.4 (17), p.12-12, Article 12

2016

Volltextzugriff (PDF)

Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine

Cancer gene therapy, 2013-12, Vol.20 (12), p.683-689

2013

Volltextzugriff (PDF)

Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2014-12, Vol.74 (6), p.1241-1250

2014

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(159)

Publikationsform

Artikel
(171)
Tagungsberichte
(3)

Sprache

Englisch
(174)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(63)
Humans
(62)
Oncology
(47)
Female
(35)
Male
(32)
Middle Aged
(31)
Adult
(29)
Aged
(29)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Tumors
(24)
Medicine, Research & Experimental
(19)
Research & Experimental Medicine
(19)
Biotechnology & Applied Microbiology
(17)
Aged, 80 And Over
(16)
Cancer
(16)
Genetics & Heredity
(15)
Neoplasms - Therapy
(14)
Care And Treatment
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

MicroRNA profile analysis of human prostate cancers

Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma

A multicenter phase 1 study of PX-866 in combination with docetaxel in patients with advanced solid tumours

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial

A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients

Transcription factors: their potential as targets for an individualized therapeutic approach to cancer

Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform

Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): Early termination due to increased toxicities

siRNA vs. shRNA: Similarities and differences

Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results

Phase I Clinical Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features

Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer

Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine

Immune response and survival of refractory cancer patients who received TGF- beta 2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine

Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference

Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study

Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine

Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors

Suchergebnisse filtern